Total Payments
$1,032
2024 Payments
$19.77
Companies
6
Transactions
41
Medicare Patients
718
Medicare Billing
$44,711
Payment Breakdown by Category
Food & Beverage$1,006 (97.5%)
Education$25.48 (2.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,006 | 39 | 97.5% |
| Education | $25.48 | 2 | 2.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $623.47 | 29 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $205.60 | 3 | $0 (2022) |
| Sunovion Pharmaceuticals Inc. | $80.95 | 4 | $0 (2020) |
| ARGENX US, INC. | $62.46 | 1 | $0 (2023) |
| UCB, Inc. | $33.62 | 2 | $0 (2017) |
| Mitsubishi Tanabe Pharma America, Inc. | $25.48 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $19.77 | 1 | ABBVIE INC. ($19.77) |
| 2023 | $199.60 | 10 | ABBVIE INC. ($137.14) |
| 2022 | $450.70 | 15 | ABBVIE INC. ($373.26) |
| 2021 | $93.30 | 5 | AbbVie Inc. ($93.30) |
| 2020 | $104.69 | 3 | Alexion Pharmaceuticals, Inc. ($61.16) |
| 2019 | $50.16 | 3 | Sunovion Pharmaceuticals Inc. ($37.42) |
| 2017 | $113.36 | 4 | Alexion Pharmaceuticals, Inc. ($67.00) |
All Payment Transactions
41 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/27/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $19.77 | General |
| Category: NEUROSCIENCE | ||||||
| 11/15/2023 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $6.41 | General |
| Category: NEUROSCIENCE | ||||||
| 11/13/2023 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $6.56 | General |
| Category: NEUROSCIENCE | ||||||
| 10/06/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $11.22 | General |
| Category: NEUROSCIENCE | ||||||
| 09/27/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $7.31 | General |
| Category: NEUROSCIENCE | ||||||
| 08/25/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $19.11 | General |
| Category: NEUROSCIENCE | ||||||
| 07/11/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $30.92 | General |
| Category: NEUROSCIENCE | ||||||
| 07/07/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: NEUROSCIENCE | ||||||
| 05/18/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $23.74 | General |
| Category: NEUROSCIENCE | ||||||
| 04/11/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $12.00 | General |
| Category: NEUROSCIENCE | ||||||
| 01/25/2023 | ARGENX US, INC. | VYVGART (Drug) | Food and Beverage | In-kind items and services | $62.46 | General |
| Category: Immunology | ||||||
| 11/02/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $25.74 | General |
| Category: NEUROSCIENCE | ||||||
| 09/13/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $27.33 | General |
| Category: NEUROSCIENCE | ||||||
| 08/08/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: NEUROSCIENCE | ||||||
| 07/28/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $29.35 | General |
| Category: NEUROSCIENCE | ||||||
| 07/05/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $23.94 | General |
| Category: NEUROSCIENCE | ||||||
| 06/15/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: NEUROSCIENCE | ||||||
| 05/19/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $124.94 | General |
| Category: NEUROSCIENCE | ||||||
| 05/10/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $22.61 | General |
| Category: NEUROSCIENCE | ||||||
| 05/09/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: NEUROSCIENCE | ||||||
| 05/05/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $10.50 | General |
| Category: NEUROSCIENCE | ||||||
| 03/23/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $14.51 | General |
| Category: NEUROSCIENCE | ||||||
| 03/15/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: NEUROSCIENCE | ||||||
| 02/03/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $20.53 | General |
| Category: NEUROSCIENCE | ||||||
| 01/25/2022 | Alexion Pharmaceuticals, Inc. | SOLIRIS (Biological) | Food and Beverage | In-kind items and services | $77.44 | General |
| Category: Rare Disease | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 167 | 199 | $52,198 | $11,540 |
| 2022 | 6 | 136 | 156 | $33,845 | $8,494 |
| 2021 | 6 | 154 | 181 | $39,740 | $9,841 |
| 2020 | 9 | 261 | 293 | $74,620 | $14,836 |
Total Patients
718
Total Services
829
Medicare Billing
$44,711
Procedure Codes
28
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 50 | 53 | $13,081 | $3,522 | 26.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 20 | 20 | $10,376 | $2,467 | 23.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 17 | 21 | $7,384 | $1,826 | 24.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 26 | 28 | $4,881 | $1,154 | 23.6% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 14 | 14 | $6,624 | $1,093 | 16.5% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 22 | 33 | $7,152 | $1,084 | 15.2% |
| 95885 | Needle measurement of electrical activity in arm or leg muscles, limited study | Office | 2023 | 18 | 30 | $2,700 | $393.07 | 14.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 33 | 34 | $11,832 | $3,434 | 29.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 39 | 42 | $10,374 | $2,595 | 25.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 24 | 24 | $3,888 | $1,113 | 28.6% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 16 | 23 | $5,060 | $697.10 | 13.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 13 | 16 | $1,280 | $414.08 | 32.4% |
| 95885 | Needle measurement of electrical activity in arm or leg muscles, limited study | Office | 2022 | 11 | 17 | $1,411 | $241.26 | 17.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 35 | 37 | $12,616 | $3,793 | 30.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 39 | 40 | $9,642 | $2,746 | 28.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 30 | 31 | $4,887 | $1,194 | 24.4% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2021 | 20 | 28 | $5,872 | $887.75 | 15.1% |
| 95909 | Nerve transmission studies, 5-6 studies | Office | 2021 | 12 | 12 | $4,104 | $741.96 | 18.1% |
| 95885 | Needle measurement and recording of electrical activity of muscles of arm or leg limited study | Office | 2021 | 18 | 33 | $2,619 | $477.30 | 18.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 64 | 69 | $16,893 | $3,605 | 21.3% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 35 | 38 | $12,899 | $2,999 | 23.3% |
| 95910 | Nerve transmission studies, 7-8 studies | Office | 2020 | 22 | 22 | $9,660 | $1,836 | 19.0% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 20 | 20 | $9,285 | $1,621 | 17.5% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2020 | 28 | 39 | $7,794 | $1,404 | 18.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 45 | 47 | $8,160 | $1,344 | 16.5% |
About Mirna Hajjar
Mirna Hajjar is a Neurology healthcare provider based in Bangor, Maine. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/10/2007. The National Provider Identifier (NPI) number assigned to this provider is 1093900441.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Mirna Hajjar has received a total of $1,032 in payments from pharmaceutical and medical device companies, with $19.77 received in 2024. These payments were reported across 41 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($1,006).
As a Medicare-enrolled provider, Hajjar has provided services to 718 Medicare beneficiaries, totaling 829 services with total Medicare billing of $44,711. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Bangor, ME
- Active Since 09/10/2007
- Last Updated 07/06/2016
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1093900441
Products in Payments
- QULIPTA (Drug) $371.79
- UBRELVY (Drug) $229.32
- SOLIRIS (Biological) $77.44
- VYVGART (Drug) $62.46
- Soliris (Drug) $61.16
- APTIOM (Drug) $56.39
- Vimpat (Drug) $33.62
- Radicava (Drug) $25.48
- KYNMOBI (Drug) $24.56
- VRAYLAR (Drug) $22.36
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Bangor
Markos Poulopoulos, M.d, M.D
Neurology — Payments: $8,705
Neurology $8,705
Enrique Feoli, M.d, M.D
Neurology — Payments: $6,994
Neurology $6,994
Carrie Downey, Do, DO
Neurology — Payments: $5,870
Neurology $5,870
Bakhtier Nurmukhamedov, M.d, M.D
Neurology — Payments: $290.15
Neurology $290.15
Tarek Wazzan, M.d, M.D
Neurology — Payments: $200.54
Neurology $200.54
Dr. Karl Sanzenbacher, M.d, M.D
Neurology — Payments: $162.77
Neurology $162.77